Skip to main content
. Author manuscript; available in PMC: 2024 Sep 15.
Published in final edited form as: Cancer. 2023 Jun 22;129(18):2773–2788. doi: 10.1002/cncr.34904

Figure 1:

Figure 1:

Algorithm for diagnosis of HER2-low BC according to the ASCO/CAP guidelines. HER2= Human epidermal growth factor receptor 2, IHC= Immuno histochemistry, ISH= In situ hybridization, CN= Copy number, avg= Average